The Double Dynamic Martin Screw (DMS) Adjustable Implant System for Proximal and Distal Femur Fractures /
The scope and importance of hip fractures is almost incomprehensible. With a world wide incidence of close to 2 million cases per year, theses fractures pose a daunting challenge to our ability to affect and treat this epidemic. Basics for operative treatment of proximal and distal femur fractures:...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Heidelberg :
Steinkopff,
2008.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Conventional hip surgery in traumatology
- A century of experiments and experiences
- Technical properties of the DMS
- The analysis of hip compression screws made of implant steel under static and limit load requirements
- Implants and instruments
- Radioanatomy
- Abnormal radiographic anatomy of the proximal femur
- Fracture classification at the proximal femur
- Statistical items
- Surgical technique for fracture treatment
- Operative procedure
- Operative procedures (Case reports)
- The prognosis of the femur neck fracture after headpreserving osteosynthesis
- Intermediate DMS (2/3 implant)
- Stabilization of intertrochanteric fractures with the Dynamic Martin Screw (DMS)
- The 31A 3-3 fracture: an unstable problem
- Subtrochanteric femur and proximal femur shaft fractures
- Application of the Dynamic Martin Screw (DMS) in the intertrochanteric osteotomy
- Distal femur fractures
- Pathologic fractures and osteolyses at the femur
- The use of an innovative femur neck prosthesis in case of complications after hip fracture surgery
- Exceptional indications
- Additional and adjuvant measurements and procedures
- Systemic antibiotics in the prophylaxis and therapy of postoperative infections in patients with osteosynthesis of the femur
- Prevention of venous thromboembolism in hip surgery
- Physiotherapy after surgery for proximal femur fractures
- Operative revisional management
- Evidence-based drug treatment of osteoporosis
- Closing remarks.